Document Detail

Maternal progesterone level in fetal growth restriction and its relationship with Doppler velocimetry indices.
Jump to Full Text
MedLine Citation:
PMID:  23329914     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
BACKGROUND/OBJECTIVE: To verify whether progesterone concentration is changed in the maternal serum of intra-uterine growth retardation (IUGR) pregnancies and to assess if there is a relationship between maternal progesterone and fetal Doppler velocimetry.
PATIENTS AND METHODS: Thirty-five patients with intrauterine growth retardation infants and thirty-seven pregnant women with appropriate for gestational age (AGA) fetuses were enrolled in the study. Maternal progesterone serum was determined. Doppler velocimetry of umbilical and middle cerebral arteries (MCA) were obtained in all fetuses.
RESULTS: Maternal progesterone level in IUGR infants (58.49±7.06 ng/ml) had no significant difference with AGA fetuses (58.13±7.87 ng/ml) (p=0.96). In the IUGR group, umbilical artery resistive index (RI), pulsatility index (PI) and systolic/diastolic (S/D) ratio were higher than the normal group (p<0.001), and MCA RI (p value=0.014) and PI (p=0.012) were significantly less than the IUGR group. Besides, RI C/U in the IUGR group was significantly less than the normal group (p<0.001). A negative significant correlation was detected between maternal progesterone level and MCA PI (r=-0.38) and RI (r=-0.38) in the AGA group.
CONCLUSION: It seems that progesterone has no effect on fetal placental circulation and serum progesterone can not discriminate IUGR infants from AGA infants. Progesterone is a poor marker for placental dysfunction.
Authors:
S Borna; M Bandarian; A Abdollahi; F Bandarian; M Malek
Related Documents :
23589794 - The prevalence of vitamin d deficiency in iron-deficient and normal children under the ...
24749774 - Postnatal changes in cerebral blood flow velocity in term intra-uterine growth-restrict...
12093954 - Urinary excretion of cross-linked n-telopeptides of type 1 collagen to assess bone reso...
24040924 - Subtle adverse effects of late preterm birth: a cautionary note.
19725894 - Relationship between infant weight gain and later asthma.
12439494 - Cost-effectiveness of induction after preterm premature rupture of the membranes.
Publication Detail:
Type:  Journal Article     Date:  2011-03-30
Journal Detail:
Title:  Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society     Volume:  8     ISSN:  1735-1065     ISO Abbreviation:  Iran J Radiol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2013-01-18     Completed Date:  2013-01-21     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  101233229     Medline TA:  Iran J Radiol     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  33-7     Citation Subset:  -    
Affiliation:
Associate Professor, Department of Perinatology, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Iran J Radiol
Journal ID (iso-abbrev): Iran J Radiol
Journal ID (publisher-id): Kowsar
ISSN: 1735-1065
ISSN: 2008-2711
Publisher: Kowsar
Article Information
Download PDF
Copyright © 2011, Tehran University of Medical Sciences and Iranian Society of Radiology
open-access:
Received Month: 6 Year: 2010
Accepted Month: 1 Year: 2011
Revision Received Month: 12 Year: 2010
Print publication date: Month: 3 Year: 2011
Electronic publication date: Day: 30 Month: 3 Year: 2011
Volume: 8 Issue: 1
First Page: 33 Last Page: 37
PubMed Id: 23329914
ID: 3522412

Maternal Progesterone Level in Fetal Growth Restriction and Its Relationship with Doppler Velocimetry Indices Alternate Title:Maternal Serum Progesterone in IUGR and Its Relationship with Doppler Indices
S. Borna1
M. Bandarian2*
A. Abdollahi3
F. Bandarian45
M. Malek6
1Associate Professor, Department of Perinatology, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2Resident of Obstetrics and Gynecology, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran
3Pathologist, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran
4PhD Student, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
5Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6Imaging Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding author: Mahin Bandarian, Department of Obstetrics and Gynecology, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Tel.: +9821 6643 9463, Fax: +9821 6642 3304, E-mail: mahbandarianmd@yahoo.com

Introduction

Intra uterine growth retardation (IUGR) is failure of the fetus to reach genetic potential for growth.[1] IUGR prevalence in developed and developing countries is 4-7% and 24-30%, respectively.[2][3][4][5][6][7] IUGR is a multifactorial disorder and maternal, fetal and placental factors can interfere with normal growth mechanisms.[8]

IUGR infants are at risk for unexplained sudden intrauterine death.[9] Perinatal mortality rate among IUGR infants is higher than normal infants.[10] IUGR causes short-term morbidities like prematurity, respiratory distress syndrome and necrotizing enterocolitis along with long-term complications such as neurologic disorders, cerebral palsy and poor neurodevelopmental outcome.[9] Low birth weight is associated with coronary heart disease, stroke, hypertension and type 2 diabetes.[11]

It is commonly accepted that IUGR is associated with impairment of uteroplacental blood flow, as a result of failure of trophoblast invasion of spiral arteries, which have not been transformed to low-resistance vessels and hence blood flow is restricted in the intervillous space.[12] Therefore, fetoplacental resistance is one of the pathophysiologic mechanisms for IUGR and vasodilator deficiency may have an effect on IUGR pregnancies.

Progesterone is a smooth muscle relaxant and also has a vasodilator effect on vasculature.[13]

Ultrasound is the most accurate and sensitive method for identifying IUGR fetuses.[14] Abnormalities in terminal villous and vascular resistance in fetoplacental circulation may be assessed by Doppler velocimetry of fetal arteries and veins. During placental dysfunction, progressive vascular redistribution can be detected in fetal circulation by high umbilical artery resistance and low cerebral vascular resistance (the brain sparing effect).[15]

The aim of this study was to verify whether the progesterone level in maternal serum of IUGR pregnancies differs from normal pregnancies, and also to determine the relationship between progesterone level and Doppler velocimetry indices of the fetus.


Patients and Methods

This case-control study was conducted among 72 pregnant women with the gestational age of 28 to 42 weeks who were referred to the perinatology clinic of Imam Khomeini Hospital for routine prenatal care and were eligible for the study. Sampling was done by census method.

IUGR was defined as fetal weight below the 10th percentile. Normal fetus was defined as fetal weight appropriate for gestational age (AGA). Thirty-five women with IUGR (case group) and 37 with a normal fetus (control group) were selected. The gestational age was determined by the first-trimester ultrasonography.

Exclusion criteria for the case group included twin pregnancy, gestational diabetes or history of diabetes mellitus, fetal anomalies, progesterone intake, and for the control group pregnancy included hypertension or preeclampsia which is also added to the previous criteria.

Informed consent was obtained from participants before enrollment and the study protocol was approved by the ethics committee of Tehran University of Medical Sciences.

All patients underwent biometric ultrasonography and Doppler velocimetry measurements. Doppler velocimetry was carried out with a commercially available instrument (L. O. GIQ500) using a 3.5-5 MHz convex probe. Doppler velocimetry consists of umbilical and middle cerebral arteries (MCA) assessment. The umbilical artery was analyzed by Pulsatility Index (PI), Resistance Index (RI), and systole to diastole ratio (S/D), while middle cerebral artery Doppler study included RI and PI. The other index was ratio of cerebral artery RI to umbilical artery RI (RI C/U). Doppler indices were calculated automatically with the software included in the ultrasound system. Maternal venous blood sample was obtained at the same day for serum progesterone assessment. Samples were centrifuged and plasma was separated and stored at -20°c until assayed.

Serum progesterone was determined by ELISA (by progesterone ELISA IBL International GmbH, Germany) intra-assay variation 5.4-6.86 (CV%) and inter-assay variation 0.96-5.59 (CV%).

Progesterone levels were adjusted according to gestational age.

Independent samples t test was applied for comparing quantitative variables with normal distribution, and Mann-Whitney U test for comparison of quantitative variables without normal distribution. Furthermore, Pearson and Spearman correlations were used to find any correlation between variables. To remove the effect of confounding factors, the multiple logistic regression model was used. P value of equal or less than 0.05 was considered statistically significant. SPSS 15 for Windows (SPSS Inc., Chicago, Illinois) was used for statistical analysis.


Results

IUGR and control groups had the same maternal age, gravity, and gestational age. As expected, in the IUGR group, the estimated fetal weight and maternal body mass index (BMI) were significantly less than the AGA group (Table 1).

Maternal progesterone in IUGR group (58.5±7.1) and AGA group (58.1±7.9) was not significantly different (p=0.96).

In IUGR group, umbilical artery RI, PI, and S/D were higher than those in the normal group, and MCA RI and PI were significantly less than those in the IUGR group. Besides, RI C/U in IUGR group was significantly less than that in the normal group (Table 2).

There were a negative correlation between the maternal progesterone level and middle cerebral RI (r=-0.38, p=0.45) and PI (r=-0.37, p=0.43) in AGA group, but such correlation was not observed in IUGR group (Fig. 1 & Fig. 2) (p=0.95).

There was no correlation between umbilical artery RI, PI, S/D and RI C/U with maternal progesterone in both groups (data not shown).

Using a multiple logistic regression model to remove confounding factors and considering IUGR as the dependent variable, C/U ratio over 1 was detected as the only independent protective factor for IUGR (p=0.003, LR=0.038, CI95%=0.004-0.34). After adjustment for confounding factors such as maternal BMI and gestational age, other variables were not significant predictors for IUGR.


Discussion

Our results showed that progesterone among IUGR and AGA groups had no significant difference. In the IUGR group, umbilical artery RI, PI and S/D were significantly higher than those in the normal group, and MCA RI and PI were lower than those in the normal group. Also in the IUGR group, RI C/U index was significantly lower than that in the normal group. In the AGA group, there was a negative correlation between progesterone and middle cerebral artery RI and PI. Up to now, investigation about such relationship between progesterone level and Doppler velocimetry indices has not been reported and we could not find a similar study on the internet. This study has assessed this relationship for the first time.

Progesterone is a vasodilator and muscle relaxant and its concentration increases during pregnancy.[13] High levels of progesterone are essential for pregnancy continuity, especially in early pregnancy.[16]

Progesterone induces a rapid vasorelaxant effect on the fetoplacental vasculature, so it can directly influence prostaglandin stimulated smooth muscle contraction.[13]

The vasodilator effect of progesterone may act by various mechanisms. As shown in a previous study, inhibition of nitric oxide reduced the progesterone vasodilatation effect in rabbit’s pulmonary artery.[17]

In one study,[18] it was demonstrated that progesterone and medroxyprogesterone acetate induced prostacyclin synthesis through dose and receptor related pathways in human umbilical venous endothelial cells. Both progesterones increased endothelial prostacyclin by enhancing cyclooxygenase-1 and 2 expression and activity.

In vivo, prostacycline (a potent vasodilator) production by placental cells in IUGR pregnancies was diminished, as compared with normal placental cells. This decrease is due to the loss of synthesis, not due to the increase of metabolism.[19]

Salas et al.[20] showed that in IUGR pregnancies, progesterone as a volume expander decreased after 30 weeks of gestational age. Yanaihara et al.[21] also obtained similar results and reported that progesterone in IUGR pregnancies was lower than that of normal pregnancies.

Ersch et al.[22] reported opposite results, as they observed that 17-Hydroxy progesterone in IUGR infants is higher than normal fetuses at the time of birth. They described this result by chronic stress in IUGR infants and 1-OHP was defined as a marker for NICU (neonatal intensive care unit) admission.

Dawood[23] did not find any significant difference in maternal serum progesterone among IUGR and AGA infants.

Lauring et al.[24] reported that progesterone had no effect on discrimination of IUGR from AGA infants, and there was no correlation between progesterone and neonatal outcome.

Our results confirmed the findings of the two previous studies [23][24] Vasodilator effects of progesterone have been reported in Paonessa et al.,[13] Li et al.[17] and Hermenegildo et al.[18] studies. Considering these reports, we expected to find a relationship between the progesterone level and Doppler velocimetry indices. We expected to see lower progesterone levels in the IUGR group with vascular resistance in the umbilical artery compared with the AGA group without vascular resistance. Despite this, a similarity was detected between progesterone levels of both case and control groups. It seems that progesterone is not a potent vasodilator to cause Doppler velocimetry changes, so it may indicate other pathophysiological mechanisms, such as prostacycline, nitric oxide, and other vasodilators other than progesterone may affect placental resistance.

Our study limitations were the wide gestational age range in the case and control groups, small sample sizes, single measurements and lack of umbilical samples.

The results of this study may be applied for early prediction and treatment of IUGR by measurement of maternal progesterone level and in low level cases it can be added to the treatment regimen. Considering the vasodilator effect of progesterone and vascular resistance in IUGR, we assumed that this resistance may be connected to progesterone level as an etiologic factor and aimed to find such a relationship. Furthermore, we could not find low levels of progesterone in IUGR cases.

However, future studies with larger sample sizes, multiple measurements with specific intervals, umbilical or placental sampling and assessment of perinatal outcome are warranted to confirm the results of the present study.


The authors wish to thank Maternal Fetal and Neonatal Research Center of Tehran University of Medical Sciences for their cooperation and support of this study.


References
1. Maulik D. Fetal growth compromise: Definitions, standards and classificationsClin Obstet GynecolYear: 2006Month: 6 492214816721101
2. Wen SW,Kramer MS,Usher RH. Comparison of birth weight distributions between Chinese and Caucasian infantsAm J EpidemiolYear: 1995Month: 6 141121177877771456
3. Paz I,Gale R,Laor A,Danon YL,Stevenson DK,Seidman DS. The cognitive outcome of full-term small for gestational age infants at late adolescenceObstet Gynecol Year: 1995Month: 3 85345267862391
4. Joseph KS,Kramer MS,Allen AC,Cyr M,Fair M,Ohlsson A,et al. Gestational age- and birthweight-specific declines in infant mortality in Canada, 1985-94. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance SystemPaediatr Perinat EpidemiolYear: 2000Month: 10 144332911101020
5. Stratulat P. Nivelul mortalităţii şi morbidităţii copiilor cu retard de creştere intrauterină în Republica MoldovaBuletin de PerinatologieYear: 20054314
6. Goldenberg RL,Hoffman HJ,Cliver SP. Neurodevelopmental outcome of small-for-gestational-age infantsEur J Clin NutrYear: 199852SupplS5489511020
7. Ancăr V. Hipotrofia fetalăYear: 1996BucureştiEditura Medicală Amaltea
8. Maulik D. Fetal growth restriction: the etiologyClin Obstet GynecolYear: 2006Month: 6 4922283516721103
9. Pallotto EK,Kilbride HW. Perinatal outcome and later implications of intrauterine growth restrictionClin Obstet GynecolYear: 2006Month: 6 4922576916721105
10. Kramer MS,Olivier M,McLean FH,Willis DM,Usher RH. Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcomePediatrics Year: 1990Month: 11 865707132235224
11. Barker FRS. Adult consequences of fetal growth restrictionClin Obstet GynecolYear: 2006Month: 6 4922708316721106
12. Khong TY,De Wolf F,Robertson WB,Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small for gestational age infantsBr J Obstet GynecolYear: 1986Month: 10 9310104959
13. Paonessa DJ,Shields AD,Howard BC,Gotkin JL,Deering SH,Hoeldtke NJ,et al. 17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619Am J Obstet GynecolYear: 2006Month: 10 19541011416846582
14. Ott WJ. Sonographic diagnosis of fetal growth restrictionClin Obstet GynecolYear: 200649229530716721108
15. Giannubilo SR,Menegazzi M,Tedeschi E,Bezzeccheri V,Suzukib H,Tranquillia AL. Doppler analysis and placental nitric oxide synthase expression during fetal growth restrictionJ Matern Fetal Neonatal MedYear: 2008Month: 9 2196172218828052
16. Progesterone level during pregnancy. [1 screen]. Available at: http://www.justmommies.com/articles/progesterone-pregnancy.shtml. Accessed April 15, 2010.
17. Li HF,Zheng Tz,Li W,Qu SY,Zhang CL. Effect of progesterone on the contractile response of isolated pulmonary artery in rabbitsCan J Physiol PharmacolYear: 2001Month: 6 7965455011430592
18. Hermenegildo C,Oviedo PJ,García-Martínez MC,García-Pérez MA,Tarín JJ,Cano A. Progestogens stimulate prostacyclin production by human endothelial cellsHum ReprodYear: 2005Month: 6 20615546115734756
19. Jogee M,Myatt L,Elder MG. Decreased prostacyclin production by placental cells in culture from pregnancies complicated fetal growth retardationBr J Obstet GynecolYear: 1983Month: 3 90324750
20. Salas SP,Marshall G,Gutiérrez BL,Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restrictionHypertensionYear: 2006Month: 2 472203816380519
21. Yanaihara T,Hirato K,Seo F,Mitsukawa G,Kojima S,Maruyama S,et al. Prenatal diagnosis of IUGR by assessing the multipel hormone concentration in maternal peripheral bloodNippon Sanka Fujinka ZasshiYear: 1984Month: 2 3621828
22. Ersch J,Beinder E,Stallmach T,Bucher HU,Torresani T. 17-Hydroxy progesterone in premature infants as a marker of intrauterine stressJ Perinat MedYear: 20083621576018211251
23. Dawood MY. Circulating maternal serum progesterone in high risk pregnanciesAm J Obstet GynecolYear: 1976Month: 7 125683240937410
24. Lauring ,Persson PH,Fernlund P. The efficiency of biochemical assays in assessing an IUGR risk-group, Preselected with ultrasound fetometryEur J Obstet Gynecol Reprod BiolYear: 1987Month: 3 243177872951284

Figures

[Figure ID: s3fig1]
Fig. 1 

Graphs show the relationship between RI of MCA and progesterone level in normal (A) and IUGR (B) groups.



[Figure ID: s3fig2]
Fig. 2 

Graphs show the relationship between PI of MCA and progesterone level in normal (A) and IUGR (B) groups.



Tables
[TableWrap ID: s3tbl1] Table 1  Baseline Characteristics of Case and Control Groups
Variable IUGR Group (mean±SD) Control Group (mean±SD) P Value
Maternal Age 29.17±6.06 28.51±3.85 0.58
Gestational Age 33.51±3.51 33.89±2.97 0.62
Parity 2.17±1.40 2.35±1.35 0.58
Estimated Fetal Weight 1614.68±493.71 2270.51±786.44 0.002a
Body Mass Index 23.43±3.86 26.70±4.42 0.003a

Fs3tbl1aa p≤0.05 Statistically Significant


[TableWrap ID: s3tbl2] Table 2  Doppler Indices in IUGR and Normal Groups
Doppler Indexes IUGR Group (mean±SD) Control Group (mean±SD) P Value
Umbilical Artery RIa 0.72±0.11 0.59±0.11 <0.001e
Umbilical Artery PIb 1.03±0.38 0.93±0.24 <0.001e
Umbilical Artery S/Dc 3.46±1.10 2.51±0.57 <0.001e
Middle Cerebral Artery RI 0.75±0.17 0.87±0.35 0.014e
Middle Cerebral Artery PI 1.45±0.45 1.91±0.86 0.012e
RI C/U Indexd 1.05±0.31 1.59±0.94 <0.001e

Fs3tbl2aa RI: resistive index

Fs3tbl2bb PI: palsatility index

Fs3tbl2cc S/D: ratio of systolic to diastolic pressure

Fs3tbl2dd Ratio of cerebral artery RI to umbilical artery RI

Fs3tbl2ee p≤0.05 statistically significant



Article Categories:
  • Urogenital Imaging

Keywords: IUGR, AGA, Progesterone, Doppler.

Previous Document:  Dual ectopic thyroid: a case report with review of literature.
Next Document:  Primary non-hodgkin B cell lymphoma in a man.